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Abstract
Background: 3 T MRI has been adopted by some centers as the primary choice for assessment of myocardial
perfusion over conventional 1.5 T MRI. However, there is no data published on the potential additional value of
incorporating semi-quantitative data from 3 T MRI. This study sought to determine the performance of qualitative
3 T stress magnetic resonance myocardial perfusion imaging (3 T-MRMPI) and the potential incremental benefit of
using a semi-quantitative perfusion technique in patients with suspected coronary artery disease (CAD).
Methods: Fifty eight patients (41 men; mean age: 59 years) referred for elective diagnostic angiography underwent
stress 3 T MRMPI with a 32-channel cardiac receiver coil. The MR protocol included gadolinium-enhanced stress
first-pass perfusion (0.56 mg/kg, dipyridamole), rest perfusion, and delayed enhancement (DE). Visual analysis was
performed in two steps. Ischemia was defined as a territory with perfusion defect at stress study but no DE or a
territory with DE but additional peri-infarcted perfusion defect at stress study. Semi-quantitative analysis was
calculated by using the upslope of the signal intensity-time curve during the first pass of contrast medium during
dipyridamole stress and at rest. ROC analysis was used to determine the MPRI threshold that maximized sensitivity.
Quantitative coronary angiography served as the reference standard with significant stenosis defined as >70 %
diameter stenosis. Diagnostic performance was determined on a per-patient and per-vessel basis.
Results: Qualitative assessment had an overall sensitivity and specificity for detecting significant stenoses of 77 %
and 80 %, respectively. By adding MPRI analysis, in cases with negative qualitative assessment, the overall sensitivity
increased to 83 %. The impact of MPRI differed depending on the territory; with the sensitivity for detection of left
circumflex (LCx) stenosis improving the most after semi-quantification analysis, (66 % versus 83 %).
Conclusions: Pure qualitative assessment of 3 T MRI had acceptable performance in detecting severe CAD. There is
no overall benefit of incorporating semi-quantitative data; however a higher sensitivity can be obtained by adding
MPRI, especially in the detection of LCx lesions.
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Background
Magnetic resonance myocardial perfusion imaging
(MRMPI) is a well-established technique for noninvasive
detection of myocardial ischemia due to coronary stenosis. Compared with single-photon emission computed
tomography (SPECT), the most widely used technique,
MRMPI has superior spatial resolution that could facilitate differentiation of subendocardial and transmural
perfusion defects. Additionally, MRMPI has fewer artifacts and is free from ionizing radiation. The vast majority of data available on MRMPI has been obtained using
a 1.5-T scanner. However, with the newly available 32channel cardiac coil and new acquisition strategies such
as k-space and time sensitivity encoding (k-t SENSE), 3T MRI system provides increased signal-to-noise ratio
(SNR), reduced imaging time, and an even greater spatial
resolution.
Over the past decade, qualitative analysis has been the
most commonly used method for MRMPI in the clinical
practice. Although studies have demonstrated that both
qualitative and semi-quantitative assessments of myocardial perfusion, using a 1.5-T scanner, have moderate
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diagnostic accuracy for the detection of coronary artery
disease (CAD) [1–3], quantitative MRMPI has the added
advantage of operator-independence and has yielded a
decrease in inter- and intra-observer variability.
The aim of this study is to investigate the performance
of 3-T stress MRMPI and the potential additional value
of semi-quantification of myocardial flow for the detection of significant CAD.

Methods
Study population

The study was approved by the Institutional Review
Board of Mackay Memorial Hospital, Taipei, Taiwan.
Sixty-four patients were recruited between September
2009 and December 2010. All patients were referred for
invasive coronary angiography due to clinically suspected or known CAD. Reasons for exclusion included
high-degree atrioventricular block, prior coronary artery
bypass surgery, pregnancy, hypotension (systolic blood
pressure < 90 mmHg), decompensated congestive heart
failure (New York Heart Association functional class III
or IV), and standard contraindications to MRI imaging,

Fig. 1 a short axis view of stress MR perfusion showing perfusion defect in the inferior wall segment (arrowhead). b corresponding rest and
stress semi-quantitative evaluation. The inferior segment shows decreased signal intensity during stress c coronary angiography of the patient
showing a stenosis of 74 % in the mid LCx (arrow)
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dipyridamole, or gadolinium. All patients were advised
not to consume caffeine within 24 h of the study. The
written informed consent was obtained from all enrolled
patients.
MRI protocol

All studies were performed on a 3-T MRI (Achieva 3 T,
Philips Medical Systems, Best, The Netherlands)
equipped with 80 mT/s maximum field gradients and a
200 T/m/s slew rate using a 32-channel cardiac receiver
coil (Invivo, Gainesville, FL) and ECG synchronization.
For myocardial perfusion imaging, a saturation recovery
gradient-echo T1 weighted sequence (T1-TFE) was used
with prospective ECG triggering; sequence parameter included: non-selected shared 90 saturation pulse, TR/TE/
flip angle: 2.2 ms/0.8 ms/10°, spatial resolution 1.8x1.8x8
mm, matrix 156x192, Sense factor 2.5–3. After the scout
images for cardiac geometry and acquisition of three
standard short axis views (apical, mid and basal) of left
ventricle, the dipyridamole infusion (0.56 mg/kg; total
duration 4 min) was started with an infusion pump
(Medrad, Indianola, PA). The stress MRMPI was performed six minutes after the beginning of dipyridamole
infusion with 0.05 mmol/kg gadolinium (Multihance,
Bracco) injected intravenously with an injection rate of
4 ml/s, followed by a 25 ml saline flush at the same rate.
Images were acquired for 60 cardiac phases. After stress
MRMPI, aminophylline was given (3 mg/kg) intravenously and delivered over 2 min. Ten minutes later, rest
MRMPI was performed using the identical protocol.
Then the following 0.05 mmol/kg gadolinium was
injected to achieve total dose of 0.15 mmol/kg. Approximately 10 min later, delayed-enhanced MR imaging (DEMR) was performed by using the inversion-recovery prepared gated fast gradient-echo sequence (1.5x1.7x5mm).
Visual MRI analysis

Two experienced readers, blinded to all data including
clinical information and angiographic results, visually
analyzed all MRI images. In cases of disagreement, consensus was achieved by use of a third reader.
Perfusion analysis of each myocardial segment (except
the apex) was performed based on the 17-segment
model recommended by the AHA (American Heart Association) [4]. Ischemia was defined as a territory with
perfusion defect at stress MRMPI but no DE-MR or a
territory with DE-MR but additional peri-infarcted perfusion defect at stress MRMPI. Diagnostic performance
was determined on a per-patient and per-vessel basis.
MPRI (Semi-quantitative MRI) analysis

All MRI images were sent to the Harrington Heart and
Vascular Institute Cardiovascular Imaging Core Laboratory (Cleveland, Ohio) for semi-quantitative perfusion

Page 3 of 7

analysis. Analyses were performed using dedicated software (CAAS-MRV, version 3.2.1, Pie Medical, Maastricht, The Netherlands) by examiners who were blinded
to angiographic results. Perfusion analysis was performed to obtain signal intensity for each myocardial
segment over time. Endocardial and epicardial contours
were drawn semi-automatically and propagated through
all slices on all images, then manually adjusted for
breathing. Mean signal intensity was registered over
time. A Signal intensity-time curve was generated from
transmural myocardium for all segments on consecutive
images before and during the contrast medium administration. The LV input function was determined by
obtaining the signal intensity-time curve of basal level
left ventricular cavity. In each signal intensity-time
curve, the maximal initial slope was determined by the
software.
LV myocardium was divided into 6 segments per slice,
and then further divided into 16 AHA segments. Myocardial perfusion reserve index (MPRI) was calculated by
dividing the results of segmental upslope at stress
through rest. All segments were assigned to the respective perfusion territory. The mean of the two lowest scoring segments was assigned to each perfusion territory
for further analysis.
Analysis of adding semi-quantitative on qualitative results

In order to exam the incremental value of semiquantitative analysis for clinical application, we selected
the segments with negative results by qualitative assessment and re-stratified them according to the semiquantitative results.
Coronary angiography and Quantitative Coronary
Analysis (QCA)

Less than two months after the MRI examination, all patients underwent conventional coronary angiography by
radial approach. Multiple cine angiographic projections
were recorded on a hard drive and subsequently sent to
the Harrington Heart and Vascular Institute Cardiovascular Imaging Core Laboratory for quantitative coronary
analysis (QCA). An expert who was blinded to visual
and quantitative CMR performed analysis using dedicated offline software (CAAS II Analysis System; Pie
Medical, Maastricht, the Netherlands). Quantitative coronary angiography was used as the gold standard and
was performed on all vessels to characterize stenosis severity. The percentage diameter of stenosis was calculated using an automated contour detection algorithm
with at least two orthogonal angiographic views. Vessels
with at least one coronary lesion of >70 % diameter stenosis were considered significant. For further analysis, the
coronary tree was divided into 16 segments for
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comparison with CMR. Territory dominance was taken
into consideration (Fig. 1).
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Table 1 Patient clinical characteristics
N = 58
Demographics

Statistical analysis

Descriptive statistics and comparisons were obtained
using SAS 9.2 (SAS Institute Inc., Cary, NC, USA.). Continuous variables were expressed as mean ± SD. Categorical variables are expressed as numbers and percentages.
Non-normally distributed variables were compared using
the Wilcoxon two-sample test. Normally distributed variables were compared using the Student’s t-test. In order
to take into account multiple measurements per subject,
vessel level analysis was performed using generalized estimating equations. Kappa values were calculated to
compare inter-observer agreement for perfusion defects
of myocardial territories on a per-patient and per-vessel
basis.
Receiver operating characteristics (ROC) analyses were
performed using R version 2.13.1 (The R Foundation for
Statistical Computing (C) 2011). ROC was used to assess
the diagnostic accuracy of visual MRI and determine the
MPRI threshold that maximized sensitivity and specificity. Diagnostic performance was determined on a perpatient and per-vessel basis. The Incremental improvement of MPRI on visual MRI is presented as sensitivity,
specificity, positive predictive value and negative predictive value.

Gender: (Female/Male)

17/41

Age (yrs)

59.47 ± 10.66

Body Weight (kg)

69.63 ± 12.56

Height (cm)

161.54 ± 10.49

BMI (kg/m2)

26.78 ± 5.34

Medical history, n (%)
Smoker

16/58 (28 %)

Former smoker

13/58 (22 %)

Diabetes

15/58 (26 %)

Hypertension

34/58 (59 %)

Dyslipidemia

28/58 (48 %)

Family History of CAD

24/58 (41 %)

Cerebral vascular accident

2/58 (3 %)

Known history of CAD

33/58 (57 %)

Known history of Angina

22/58 (38 %)

Known history of myocardial infarction

9/58 (16 %)

Know history of PCI or stent implantation

6/58 (10 %)

Lab data
Total Cholesterol, mg/dl

186.17 ± 40.23

Triglyceride, mg/dl

141.09 ± 70.40

LDL, mg/dl

113.36 ± 32.55

Results

HDL, mg/dl

41.57 ± 19.34

Incremental value of MPRI

Medication, n (%)

MRI was successfully performed without any side effects
related to gadolinium or dipyridamole in 64 patients. A
total of 58 patients (Table 1) had CMR results available
for MPRI calculation, as 6 patients were excluded due to
poor image quality, due to the presence of significant
artifact. A total of 162 coronary territories were available
for analysis. There were a total of fifty coronary territories with perfusion defects and twelve with delayed enhancement (DE). In forty-three coronary territories with
perfusion defect but no DE, thirty two territories showed
subendocardial perfusion defects (involving less than
50 % of LV wall thickness) and the rest showed transmural perfusion defects.
The prevalence of significant coronary artery stenosis
(>70 %) was 31 % (18 of 58 patients), including ten patients with single-vessel disease, seven patients with
double-vessel disease and one patient with triple-vessel
disease. At the patient level, using QCA as the gold
standard, qualitative MRI had a sensitivity and specificity
of 77 and 80 % respectively. ROC analyses resulted in a
MPRI value of 0.818, providing the optimal sensitivity
and specificity to detect CAD at >70 % stenosis of 58
and 74 %, respectively, and a positive and negative predictive value of 52 and 78 % (AUC of 0.63), respectively.

Aspirin

35/58 (60 %)

ß-blocker

27/58 (47 %)

Statin

30/58 (52 %)

CAD classification
One vessel

10/58 (17 %)

Two vessel

7/58 (12 %)

Three vessel

1/58 (2 %)

None

40/58 (69 %)

Hemodynamic data
Heart rate at stress (beats/min)

78.21 ± 8.55

Heart rate at rest (beats/min)

71 ± 8.07

Systolic BP at stress (mmHg)

126.81 ± 14.82

Diastolic BP at stress (mmHg)

79.67 ± 9.85

LDL Low-density lipoprotein, HDL High-density lipoprotein, PCI percutaneous
coronary intervention

The additional information provided by the semiquantitative MRI data produced some improvement in
the sensitivity but a disproportional loss of specificity. At
a patient level analysis, the use of MPRI resulted in an
increase in sensitivity (83 vs. 77 %), but a decrease in
specificity (63 vs. 80 %). Similarly, at the vessel level, the
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use of MPRI information produced a small increase in
sensitivity (84 % vs. 76 %) but a larger loss of specificity
(77 % vs.91 %) (Table 2). Further stratification by territory revealed the same pattern of gain in sensitivity associated with a loss in specificity. For example, a subanalysis of diagnostic performance in the LCx territory
showed an increase in sensitivity from 66 to 83 %, with a
decrement in specificity from 93 to 75 % (Table 3).

Table 3 Sensitivity and specificity of qualitative MRI with and
without additional MPRI information by vessel level
LAD

LCx

RCA

Qualitative

MPRI

Qualitative

MPRI

Qualitative

MPRI

Sensitivity

80 %

90 %

66 %

83 %

77 %

77 %

Specificity

92 %

79 %

93 %

75 %

88 %

81 %

MPRI cutoff: 0.818
LAD left anterior descending, LCx left circumflex, RCA right coronary artery,
MPRI myocardial perfusion reserve index

Inter-observer agreement

Of the 58 patients, there was agreement in the determination of myocardial ischemia in 52 (90 %,κ = 0.79) on a
per-patient basis. For coronary territories, there was
agreement in 52 patients for LAD (90 %,κ = 0.72), 53 patients for LCx (91 %,κ = 0.69) and 53 patients for RCA
(91 %,κ = 0.77).

Discussion
This study is the first to report on the diagnostic performance of 3-T MRMPI combining visual and semiquantitative analysis in detecting significant coronary
stenosis in symptomatic patients. The main findings of
our study are as follows: First, qualitative 3-T MRMPI
has moderate accuracy in detecting significant coronary
artery stenosis defined as >70 % luminal narrowing. Second, semi-quantitative assessment of 3-T MRMPI is specific but with low sensitivity. Third, the addition of
semi-quantitative methods in cases with initial negative
results on visual assessment provided superior sensitivity
but, with decreased specificity. Forth, the impact of adding semi-quantitative on qualitative assessment was most
effective for the LCx territory. Most importantly, we
demonstrated that a stepwise strategy of applying semiquantification in an initially qualitatively negative assessment could improve the sensitivity for detection of significant CAD, highlighting the potential utility as a
screening tool.
SPECT myocardial perfusion imaging plays a major
role in the field of cardiovascular imaging for detecting
physiologically significant CAD. It also provides robust
prognostic information to physicians and patients [5–7].
However, SPECT has several limitations. There is poor
spatial resolution that can lead to false negative results
in the setting of balanced ischemia due to multi-vessel
disease. Also, attenuation artifacts are a common
Table 2 Sensitivity and specificity of qualitative MRI with and
without additional MPRI information
Patient level

All vessels

Qualitative

MPRI

Qualitative

MPRI

Sensitivity

77 %

83 %

76 %

84 %

Specificity

80 %

63 %

91 %

77 %

MPRI myocardial perfusion reserve index

occurrence in obese patients and women [8]. Prior studies of 1.5-T MRMPI have shown that it yields high diagnostic accuracy compared to quantitative coronary
angiography in detection of coronary artery disease
while avoiding ionizing radiation exposure [9]. However,
3-T MRI is a relatively unpopular technique in cardiac
imaging due to inhomogeneity in the high magnetic
field, and increased susceptibility of artifacts [10]. With
double the magnetization from 1.5-T to 3-T, a higher
signal-to-noise ratio, and better tissue contrast [11], 3-T
MRMPI shows promise for a future role in clinical practice. Recently, 3-T MR myocardial perfusion was compared head to head with 1.5-T, and 3 T MR and showed
superior diagnostic accuracy in prediction of single and
multivessel disease with increased contrast-to-noise and
tissue-to-noise ratios [12].
Clinically, qualitative analysis is the most common
method used in MR myocardial perfusion. There are
only few studies [12–14] directly comparing pure qualitative 3-T MR myocardial perfusion with significant coronary stenosis (>70 %) on angiography. One study
reported sensitivity of 89 to 100 %, specificity of 55 to
79 % and diagnostic accuracy of 77 to 85 % in perpatient level analyses as compared with 77 % sensitivity,
80 % specificity and 79.3 % accuracy in the current study
[12, 14, 15]. However, qualitative assessment of MRMPI
in 1.5-T has been reported to be operator-dependent
with inter-observer variability as well as inferior performance compared to semi-quantitative assessment [16,
17]. Our results revealed the improvement of sensitivity
by combing qualitative and semi-quantitative analysis in
3-T MRMPI.
Nevertheless, the observed increase in sensitivity by
adding the semi-quantitative assessment on the initial
negative results cases in visual assessment cannot translate into an improved diagnostic accuracy due to a significant decrease in specificity. This might be explained
by several factors. First, semi-quantitative analysis is reported superior to visual analysis in diagnostic performance but still is a time consuming and cumbersome
post-processing method, and it has rarely been performed in clinical practice. Therefore, we only applied
semi-quantitative assessment on initial negative results
cases from visual assessment. Secondly, previous studies
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have demonstrated that the diagnostic performance of
stress MR myocardial perfusion depends on the severity
of coronary stenosis detected on QCA [12, 18]. Cheng et
al. [12] showed a reduced specificity for detection of
stenosis of ≥70 % versus stenosis of ≥50 % in 3.0 T perfusion CMR. Klein et al. [18] also found that the detection of coronary stenosis of ≥70 %, as opposed to ≥50 %,
resulted in a reduction in specificity from 63 % to 58 %
in a 1.5 T study combining both perfusion and LGE imaging in a visual interpretation. By comparison, Ikuye et
al. [19] showed good to moderate value in diagnostic accuracy in LAD and RCA but poor value in LCx territory
by semi-quantitative assessment of 3-T myocardial perfusion, compared with quantitative coronary angiography ≥70 % stenosis. Our results demonstrated the
most significant improvement in sensitivity but with
moderate to severe decrement in specificity in the LCx
territory, in sub-analysis at the vessel level, when combining qualitative and semi-quantitative analysis.
Limitations

There were several limitations of the present study. First,
coronary angiography is not a truly gold reference standard for myocardial perfusion images but remains the
most established technique for decision making in interventional cardiology. In coronary lesions with stenosis
over 70 % but, with normal myocardial perfusion, the
diagnostic performance might not be assessed accurately. On the other hand, the stenosis grade of angiography cannot provide a reference in the setting of
microvascular disease leading to CMR perfusion defect.
Second, we did not compare CMR perfusion with
SPECT, the most popular myocardial perfusion technique or other advanced functional studies including invasive fractional flow reserve (FFR), stress PET, stress/
FFR CT. Third, the dose of dypiridamole in our study is
not a high dose protocol which may fail to induce myocardial perfusion defects in some cases. Finally, we did
not perform full-quantification of MR myocardial perfusion, which demonstrated close correlation to the results
of FFR in hemodynamic significance of coronary artery
disease.

Conclusion
The results of our study show that performance of the
pure qualitative assessment 3-T cardiac MRI in detecting
significant coronary artery disease is acceptable. By adding semi-quantitative analysis, the sensitivity was increased, particularly in the detection of LCx lesions.
Abbreviations
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